← Back to Search

Arthroscopic Surgery vs Non-Operative Treatment for Tennis Elbow

N/A

Recruiting

Led By J W Pollock, MD

Research Sponsored by Ottawa Hospital Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Symptoms consistent with lateral epicondylitis persisting for >6 months, and have failed conservative management

Adult, skeletally mature (>18yrs)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from time of enrollment up until 2-years post-operative

Awards & highlights

Study Summary

This trial will compare two different surgical treatments for chronic tennis elbow in order to determine which is more effective.

Who is the study for?

This trial is for individuals who have been experiencing tennis elbow symptoms for at least 9 months and haven't improved with standard treatments. It's not suitable for those with workers' compensation claims, previous severe elbow injuries or surgeries, or other conditions that better explain their symptoms.Check my eligibility

What is being tested?

The study is comparing two surgical methods to treat chronic tennis elbow: arthroscopic release versus arthroscopic debridement. Participants will be randomly assigned to one of the procedures in a double-blind setting to determine which is more effective.See study design

What are the potential side effects?

Potential side effects may include pain at the surgery site, swelling, stiffness in the elbow, infection risk from surgery, and possible damage to nearby nerves or blood vessels during the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had tennis elbow symptoms for over 6 months and treatments haven't worked.

Select...

I am over 18 years old and my bones have stopped growing.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from time of enrollment up until 2-years post-operative

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from time of enrollment up until 2-years post-operative

This trial's timeline: 3 weeks for screening, Varies for treatment, and from time of enrollment up until 2-years post-operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Mayo Elbow Performance Score

Secondary outcome measures

Adverse Events

Elbow

Hand

+2 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Arthroscopic tennis elbow releaseActive Control1 Intervention

This group will have arthroscopic tennis elbow release through a standard, two-portal technique,

Group II: Non OperativePlacebo Group1 Intervention

control group will not undergo a second portal or muscle release.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor

561 Previous Clinical Trials

2,785,626 Total Patients Enrolled

J W Pollock, MDPrincipal InvestigatorThe Ottawa Hospital

Media Library

Arthroscopic tennis elbow release Clinical Trial Eligibility Overview. Trial Name: NCT02236689 — N/A

Tennis Elbow Research Study Groups: Arthroscopic tennis elbow release, Non Operative

Tennis Elbow Clinical Trial 2023: Arthroscopic tennis elbow release Highlights & Side Effects. Trial Name: NCT02236689 — N/A

Arthroscopic tennis elbow release 2023 Treatment Timeline for Medical Study. Trial Name: NCT02236689 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment limit for this clinical trial?

"Affirmative. Clinicaltrials.gov denotes that this research program, which was inaugurated on April 1st 2016, is currently recruiting participants. 68 individuals must be recruited from a single facility for the trial to proceed as planned."

Answered by AI

Are there available vacancies for participants in this trial?

"Affirmative. Clinicaltrials.gov's information indicates that the trial, which first appeared on April 1st 2016, is actively looking for 68 participants from a single site to take part in this research."

Answered by AI

Is this research experiment open to participants of all ages, or is there an age limit?

"To be eligible for this medical trial, the minimum age requirement is 18 while the maximum age limit stands at 90."

Answered by AI

What eligibility requirements must be met to participate in this research?

"68 individuals with tennis elbow, ranging from 18 to 90 years of age are being accepted into this research. Crucially, applicants must have struggled with their condition for at least 9 months and attempted other treatments first."

Answered by AI

Recent research and studies

BMC Musculoskeletal DisordersJournal

A Randomized, Double-blind Sham-controlled Trial on the Efficacy of Arthroscopic Tennis Elbow Release for the Management of Chronic Lateral Epicondylitis

Matache, Bogdan A., Randa Berdusco, Franco Momoli, Peter L. C. Lapner, and J. W. Pollock. 2016. “A Randomized, Double-blind Sham-controlled Trial on the Efficacy of Arthroscopic Tennis Elbow Release for the Management of Chronic Lateral Epicondylitis”. BMC Musculoskeletal Disorders. Springer Science and Business Media LLC. doi:10.1186/s12891-016-1093-9.

clinicaltrials.govStudy

Comparing Arthroscopic Tennis Elbow Release With Arthroscopic Debridement

2016. "Comparing Arthroscopic Tennis Elbow Release With Arthroscopic Debridement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02236689.